Assisted reproductive technology, usually called ART, refers to any medical procedure in which eggs, sperm, or embryos are handled outside the body to help someone become pregnant. The most familiar form is in vitro fertilization, or IVF, but the umbrella also covers techniques like intracytoplasmic sperm injection (ICSI), embryo freezing, egg donation, and gestational surrogacy. An international committee convened by the World Health Organization has standardized definitions for 87 terms related to these procedures, reflecting how sprawling the field has become since the first IVF baby was born in 1978.
A Brief Origin Story
On July 25, 1978, Louise Brown was delivered by cesarean section at Oldham Hospital in England, weighing five pounds and twelve ounces. Her birth marked the first successful human IVF pregnancy and launched what has become a global medical industry.1PubMed Central. Assisted Reproductive Technology after the Birth of Louise Brown In the decades since, millions of children have been born through ART worldwide, and the technologies used to create them have changed dramatically. What was once a single experimental procedure has branched into a family of techniques, each suited to different causes of infertility.
How IVF Works, Step by Step
A standard IVF cycle moves through several distinct phases. Understanding the sequence helps make sense of the variations and add-ons clinics now offer.
Ovarian Stimulation and Egg Retrieval
In a natural menstrual cycle, you typically release one mature egg. During IVF, fertility medications stimulate the ovaries to produce roughly five to ten mature eggs at once.2PubMed Central. ESHRE guideline: ovarian stimulation for IVF/ICSI This controlled overstimulation increases the chances of getting at least a few viable embryos from a single cycle. Once the eggs reach the right size, they are collected through a brief ultrasound-guided procedure that uses a thin needle passed through the vaginal wall.
The stimulation phase does carry risks. The most notable is ovarian hyperstimulation syndrome (OHSS), where the ovaries over-respond and fluid leaks from blood vessels into surrounding tissues. In one large study of women with polycystic ovary syndrome (PCOS), who are especially prone to this complication, about a quarter developed some degree of OHSS during their IVF cycles.3PubMed Central. Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI The condition ranges from mild bloating and discomfort to, in rare cases, serious fluid buildup that requires hospitalization. Vascular endothelial growth factor (VEGF) appears to play a central role in triggering the capillary leakage that drives the syndrome.4PubMed Central. Ovarian Hyperstimulation Syndrome: Current Views on Pathophysiology, Risk Factors, Prevention, and Management
Fertilization in the Lab
Once eggs are retrieved, they are combined with sperm in one of two ways. In conventional IVF, eggs and sperm are placed together in a dish and fertilization happens on its own. In ICSI, a single sperm is injected directly into each egg using a microscopic needle. ICSI was developed for cases of severe male infertility, where sperm counts or motility are too low for conventional fertilization to work reliably.
Over time, many clinics began using ICSI routinely, even when sperm quality was normal. A recent randomized trial challenged that practice: among couples without severe male factor infertility, the cumulative live birth rate was about 47% with conventional IVF and 43% with ICSI, a difference that was not statistically meaningful.5Nature Medicine. IVF versus ICSI in patients without severe male factor infertility: a randomized clinical trial The takeaway is that ICSI does not improve outcomes when sperm quality is normal or only mildly reduced, and conventional IVF remains the appropriate default in those cases.
Embryo Culture and Transfer
Fertilized eggs are grown in carefully formulated culture media for three to six days, developing from single cells into multicellular embryos. By around day five, the most viable embryos typically reach the blastocyst stage. The composition of culture media matters more than most patients realize; researchers continue to refine glucose concentrations and nutrient profiles to better mimic the conditions inside the fallopian tube and uterus.6Human Reproduction. The composition of commercially available human embryo culture media At the end of the culture period, one or more embryos are transferred into the uterus through a thin catheter, a procedure that is usually painless and takes only a few minutes.
In Vitro Maturation as an Alternative
Not everyone can safely undergo full ovarian stimulation. In vitro maturation, or IVM, offers a workaround: immature eggs are collected from the ovaries with little or no hormonal stimulation and then matured in the lab. This approach is especially relevant for women at high risk of OHSS, those who need urgent fertility preservation before cancer treatment, and situations where stimulation is simply not feasible.7PubMed Central. In vitro maturation (IVM) of human immature oocytes: is it still relevant? IVM cuts costs, shortens treatment time, and nearly eliminates the risk of hyperstimulation.
The trade-off is lower success rates compared to conventional IVF. Pregnancy rates after IVM remain below those achieved with full stimulation, and the technique demands specialized lab expertise that not all clinics have.8PubMed Central. In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities For now, IVM occupies a niche role rather than a mainstream one, though ongoing research into optimizing culture conditions could narrow the gap.
Freezing Embryos and Eggs
The ability to freeze and later thaw embryos changed ART profoundly. It means extra embryos from a single cycle can be preserved for years, giving patients multiple transfer attempts without repeating the stimulation and retrieval process. Two main freezing methods exist: traditional slow freezing and vitrification, an ultra-rapid technique that plunges cells into liquid nitrogen so fast that ice crystals cannot form.
Vitrification has largely replaced slow freezing over the past fifteen years. A meta-analysis pooling data from seven randomized trials found that vitrified embryos had significantly higher survival rates after thawing than slowly frozen ones.9Human Reproduction Update. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance Additional research confirms that vitrification produces less damage to embryo structure and yields better pregnancy rates overall.10International Journal of Progressive Sciences and Technologies. Post Thawing Survival Rate Of Human Embryos In Slow Freezing Versus Vitrification: A Narrative Review At the blastocyst stage, optimized vitrification protocols can achieve survival and implantation rates comparable to transferring fresh embryos.11Human Reproduction Update. A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos
Fresh Versus Frozen Embryo Transfer
Given how well embryos survive vitrification, a natural question is whether it is better to transfer an embryo fresh during the same cycle it was created, or freeze everything and transfer in a later cycle. Multiple meta-analyses now lean toward frozen embryo transfer (FET) for many patients. One analysis of randomized trials found that live birth rates were about 18% higher and miscarriage rates substantially lower with FET compared to fresh transfer.12PubMed. Clinical outcomes of frozen embryo versus fresh embryo transfer following in vitro fertilization: a meta-analysis of randomized controlled trials A separate systematic review found higher clinical and ongoing pregnancy rates with FET, likely because the uterine lining has time to recover from stimulation drugs and is better synchronized with the embryo.13PubMed. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis
Frozen transfer also dramatically lowers the risk of moderate to severe OHSS, since the ovaries have time to settle before pregnancy hormones enter the picture.12PubMed. Clinical outcomes of frozen embryo versus fresh embryo transfer following in vitro fertilization: a meta-analysis of randomized controlled trials This “freeze-all” strategy has become increasingly popular worldwide, particularly in countries like Japan and Australia, where the shift to frozen transfers has coincided with a sharp drop in multiple pregnancy rates.14PubMed Central. Systematic review of worldwide trends in assisted reproductive technology 2004-2013
Genetic Testing Before Transfer
Preimplantation genetic testing, or PGT, allows clinicians to screen embryos for chromosome abnormalities or specific inherited conditions before they are placed in the uterus. The most common form screens for aneuploidy — having too many or too few chromosomes — which is a leading cause of implantation failure and early miscarriage. Testing typically involves removing a few cells from the outer layer of a blastocyst (a trophectoderm biopsy) and analyzing the DNA using next-generation sequencing.
A systematic review and meta-analysis found that trophectoderm biopsy has good but imperfect accuracy, with sensitivity around 84% and specificity near 79%.15PubMed Central. The diagnostic accuracy of preimplantation genetic testing in assessing the genetic status of embryos: a systematic review and meta-analysis One complication is mosaicism, where some cells in an embryo have abnormal chromosomes while others are normal. Modern sequencing platforms are better at detecting mosaicism, but this creates a clinical puzzle: some mosaic embryos may correct themselves after implantation and develop into healthy pregnancies, while others will not.16PubMed. Should every embryo undergo preimplantation genetic testing for aneuploidy? A review of the modern approach to in vitro fertilization The decision about whether to transfer a mosaic embryo remains one of the most debated questions in reproductive medicine.
One frontier that could eventually make biopsy unnecessary is non-invasive PGT. Instead of removing cells, this approach analyzes DNA that embryos naturally shed into the surrounding culture fluid. Early studies show promising concordance with traditional biopsy results — one found an overall agreement rate of about 83% — and in some cases it may actually be more reflective of the embryo’s true genetic makeup, since trophectoderm cells do not always match the inner cell mass that becomes the baby.17PubMed Central. Noninvasive preimplantation genetic testing for aneuploidy using blastocyst spent culture medium may serve as a backup of trophectoderm biopsy in conventional preimplantation genetic testing Another study found that, when done carefully, non-invasive testing was less prone to errors associated with embryo mosaicism than conventional biopsy.18PubMed Central. Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsy The technology is not yet ready to replace biopsy in routine practice, but it is moving in that direction.
How Age Affects Success Rates
Maternal age is the single strongest predictor of IVF success. An analysis of over 33,000 single embryo transfers found that live birth rates begin to drop meaningfully around age 40 and that the risk of implantation failure climbs about 4% per year after that threshold.19PubMed. Advanced maternal age was associated with an annual decline in reproductive success despite use of donor oocytes: a retrospective study This decline is driven primarily by egg quality: older eggs are more likely to have chromosomal errors, which lead to failed implantation or miscarriage.
Using donor eggs from younger women largely sidesteps the egg-quality problem. A study of women aged 45 and older who received donor eggs found a stable live birth rate of about 40% per transfer cycle, and cumulative success rates above 50% even for women over 50.20PubMed. IVF and obstetric outcomes among women of advanced maternal age (≥45 years) using donor eggs These numbers make clear that the uterus itself remains functional well past the age when a woman’s own eggs become unreliable. That said, pregnancy at any advanced age carries higher obstetric risks — gestational diabetes, preeclampsia, and cesarean delivery are all more common — regardless of where the egg came from.
Surgical Sperm Retrieval for Male Factor Infertility
About 5% of infertile couples face azoospermia, meaning no sperm are found in the ejaculate.21Cochrane Database of Systematic Reviews. Surgical sperm retrieval techniques for obstructive and non-obstructive azoospermia This can happen because of a blockage in the reproductive tract (obstructive azoospermia) or because the testes produce extremely low quantities of sperm (non-obstructive azoospermia). In either case, sperm can often be surgically retrieved directly from the epididymis or testis and then used with ICSI to achieve fertilization.22PubMed Central. Surgical sperm retrieval: Techniques and their indications
For non-obstructive cases, microdissection testicular sperm extraction (micro-TESE) uses a surgical microscope to locate tiny pockets of active sperm production within the testis. This approach improves the yield of usable sperm while minimizing damage to the surrounding tissue.23PubMed Central. Updates on sperm retrieval techniques The development of these surgical techniques, paired with ICSI, has meant that men who would have been considered irreversibly infertile a generation ago now have a realistic path to biological parenthood.
Risks to Children Conceived Through ART
Most children born through ART are healthy. But large-scale data consistently show a modestly elevated rate of certain complications compared to naturally conceived children. A meta-analysis found that ART-conceived infants had about a 22% higher overall likelihood of birth defects, with cardiovascular defects showing the largest increase (about 51% higher odds) and smaller but statistically meaningful increases in urogenital, nervous system, and orofacial defects.24PubMed Central. Risk of birth defects in children conceived with assisted reproductive technology: A meta-analysis
Fresh embryo transfers are associated with higher rates of preterm birth and low birth weight, while frozen transfers are linked to the opposite pattern: babies that are larger than expected for their gestational age.25PubMed. Long-term outcomes for children conceived by assisted reproductive technology It is not entirely clear how much of the added risk comes from the ART procedures themselves versus the underlying infertility that led to treatment in the first place. Some researchers suspect that hormonal stimulation and the artificial lab environment during the earliest days of development could cause subtle epigenetic changes — alterations in how genes are switched on or off without changing the DNA sequence itself.26PubMed Central. Long-Term Effects of ART on the Health of the Offspring Long-term follow-up data on ART-conceived adults remain limited, and teasing apart the effects of infertility, treatment, and chance is an ongoing challenge.27PubMed Central. Long-term follow-up of children conceived through assisted reproductive technology
Third-Party Reproduction
When a person or couple cannot provide their own eggs, sperm, or a uterus, ART extends to include donated gametes and gestational carriers. Egg donation is widely used by women whose own eggs are unlikely to produce viable embryos — whether because of age, premature ovarian insufficiency, or genetic risk. Sperm donation has been available for far longer, predating IVF entirely, though it is now typically combined with IUI (intrauterine insemination) or IVF depending on the clinical situation.
Gestational surrogacy, where another person carries and delivers the baby, raises complex ethical and psychological questions. Research suggests that gestational carriers generally do well after the pregnancy, provided there is careful screening and counseling beforehand. Most do not experience lasting psychological harm, though some report transient distress when handing the child over, and rare cases involve a carrier wanting to keep the baby.28PubMed Central. Ethical considerations on surrogacy Public attitudes toward these arrangements vary widely by culture. A national survey in Japan found that about 41% of respondents approved of gestational surrogacy, while roughly 22% disapproved; nearly half agreed that children born through these arrangements have a right to know their genetic origins.29PLoS ONE. A survey of public attitudes towards third-party reproduction in Japan in 2014 Legal frameworks for surrogacy range from fully regulated to outright banned, depending on the country.
Cost, Access, and Who Gets Left Out
ART is expensive, and who can afford it shapes who uses it. In Australia, where a national insurance scheme partially covers IVF, women in the highest socioeconomic bracket still used ART at roughly twice the rate of those in the lowest bracket. When out-of-pocket costs for a fresh IVF cycle rose from about $1,500 to $2,500 Australian dollars, usage dropped by 21 to 25% across all income levels.30Human Reproduction. Socioeconomic disparities in access to ART treatment and the differential impact of a policy that increased consumer costs In countries without public subsidies, costs are substantially higher, and the disparity is steeper.
Cost barriers do not just prevent people from starting treatment — they distort the treatment decisions of those who do. Research on patients and providers in settings with limited insurance coverage found that both sides make trade-offs to maximize pregnancy chances while minimizing expense, sometimes resulting in riskier approaches like transferring multiple embryos instead of one.31PubMed. The Impact of Access Barriers on Fertility Treatment Decision Making: A Qualitative Study From the Perspectives of Patients and Service Providers Many patients also face geographic barriers, having to travel to urban centers for specialized care and absorbing lodging and time-off-work costs on top of the treatment itself. The result is that the populations with the highest unmet need for fertility care are often the least likely to receive it.
AI and Embryo Selection
Choosing which embryo to transfer has traditionally depended on a trained embryologist looking at the embryo under a microscope and grading its appearance. This is inherently subjective, and researchers are now exploring whether artificial intelligence can do it more consistently. Time-lapse monitoring systems that photograph embryos every few minutes throughout development generate enormous amounts of visual data, and AI models can analyze these images to pick up patterns that may predict which embryos are most likely to implant.32PubMed Central. Use of time-lapse technology and artificial intelligence in the embryology laboratory: an updated review
The promise is real, but so is the gap between promise and current performance. One study that trained a deep-learning model on time-lapse images of matched high-quality embryos achieved only modest accuracy in predicting pregnancy outcomes, with sensitivity around 54% and specificity around 68%.33Scientific Reports. Deep-learning model for embryo selection using time-lapse imaging of matched high-quality embryos Those numbers suggest that AI can detect something real in embryo development patterns, but it is far from replacing the clinical judgment of an experienced embryologist. The field’s expectation is that AI will eventually serve as a decision-support tool — offering an additional data layer alongside traditional morphology and genetic testing — rather than a standalone oracle.
Making Eggs and Sperm from Stem Cells
The most speculative technology on the ART horizon is in vitro gametogenesis (IVG): creating functional eggs or sperm from a patient’s own skin or blood cells, reprogrammed through stem cell techniques. In mice, researchers have already produced viable oocytes from stem cells that went on to yield healthy, fertile offspring. In humans, the work has progressed to generating early-stage egg cells and sperm precursors, but no one has yet produced a fully functional human gamete this way.34PubMed. Mammalian in vitro gametogenesis
If IVG were ever perfected for clinical use, it could transform fertility medicine. Same-sex couples could have children genetically related to both partners. Women who have lost ovarian function would not need egg donors. People who underwent chemotherapy as children might still produce genetically related offspring decades later. The technical hurdles are enormous — artificial gametes would need to faithfully recapitulate all the genetic and epigenetic processes of natural egg and sperm development to ensure the health of any resulting child.35PubMed Central. Artificial gametes from stem cells The ethical questions are equally daunting. For now, IVG remains a laboratory pursuit, but it is one that fertility researchers watch more closely than almost anything else in the field.
Global Trends in How ART Is Practiced
The way ART is used varies dramatically by country, shaped by regulation, insurance coverage, cultural preferences, and clinical philosophy. A worldwide review of trends from 2004 to 2013 illustrates the divergence. In Japan, the adoption of minimal stimulation protocols and a near-universal shift to single embryo transfer dropped the fresh-cycle live birth rate to about 5%, far below the roughly 29% seen in the United States during the same period. But that comparison is misleading if you look only at fresh cycles: Japan’s aggressive use of frozen embryo transfer and its policy of transferring just one embryo at a time yielded a multiple delivery rate of only 4%, compared to 27% in the U.S.14PubMed Central. Systematic review of worldwide trends in assisted reproductive technology 2004-2013
That trade-off captures a philosophical split in the field. Some systems prioritize per-cycle live birth rates, which often means transferring more embryos and accepting higher twin and triplet rates. Others prioritize the safety of both the mother and the baby, accepting lower per-cycle success in exchange for dramatically fewer multiple pregnancies. Twin and higher-order pregnancies carry substantial risks: preterm delivery, low birth weight, neonatal intensive care, and maternal complications like preeclampsia. The global trend is firmly toward single embryo transfer, and the rising success of vitrification and frozen transfer has made that shift easier to justify clinically.